Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.05
+1.10 (4.24%)
Jul 17, 2025, 1:35 PM CST
-3.39%
Market Cap949.90M
Revenue (ttm)690.03M
Net Income (ttm)-53.54M
Shares Out36.61M
EPS (ttm)-1.46
PE Ration/a
Forward PEn/a
Dividend0.25 (0.96%)
Ex-Dividend DateJun 21, 2024
Volume1,010
Average Volume27,016
Open26.20
Previous Close25.95
Day's Range26.20 - 27.05
52-Week Range18.50 - 28.25
Beta0.77
RSI63.71
Earnings DateAug 8, 2025

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. It supp... [Read more]

Sector Healthcare
Founded 1962
Employees 210
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.